相互作用
Bazedoxifene-conjugated estrogens + Somapacitan
重症度: 中等度
Bazedoxifene-conjugated estrogens and Somapacitan: moderate interaction.
最終更新日
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
概要
Oral estrogens reduce hepatic IGF-1 production in response to growth hormone, so patients taking somapacitan may have a blunted IGF-1 response. Higher somapacitan doses may be needed when oral estrogen is started, and dose reduction may be needed if it is stopped.
この相互作用をわかりやすく説明すると
Bazedoxifene-conjugated estrogens and Somapacitan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Bazedoxifene-conjugated estrogens belongs to Endocrine; Somapacitan belongs to Endocrine.
なぜ起こるのか
First-pass hepatic exposure to oral estrogen suppresses growth hormone-induced IGF-1 generation in the liver.
対処法
Monitor serum IGF-1 and clinical response, and titrate the somapacitan dose when starting or stopping the estrogen. Consider a non-oral estrogen route if clinically appropriate.
薬剤師に尋ねること
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、Bazedoxifene-conjugated estrogensとSomapacitanの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
WebでPro+を7日間無料でお試し。カード登録不要。
Bazedoxifene-conjugated estrogensのその他の相互作用
- Anastrozole + Bazedoxifene-conjugated estrogens 併用禁忌
- Bazedoxifene-conjugated estrogens + Ospemifene 併用禁忌
- Antithrombin alfa + Bazedoxifene-conjugated estrogens 重大
- Antithrombin iii + Bazedoxifene-conjugated estrogens 重大
- Bazedoxifene-conjugated estrogens + Bemiparin 重大
- Bazedoxifene-conjugated estrogens + Carbamazepine 重大
Somapacitanのその他の相互作用
よくある質問
Can I take Bazedoxifene-conjugated estrogens with Somapacitan?
MediHelp rates the interaction as moderate. Bazedoxifene-conjugated estrogens and Somapacitan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Oral estrogens reduce hepatic IGF-1 production in response to growth hormone, so patients taking somapacitan may have a blunted IGF-1 response. Higher somapacitan doses may be needed when oral estrogen is started, and dose reduction may be needed if it is stopped.
How serious is the interaction between Bazedoxifene-conjugated estrogens and Somapacitan?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum IGF-1 and clinical response, and titrate the somapacitan dose when starting or stopping the estrogen. Consider a non-oral estrogen route if clinically appropriate.
What other medicines interact with Bazedoxifene-conjugated estrogens?
MediHelp also lists interactions of Bazedoxifene-conjugated estrogens with, for example, Anastrozole, Ospemifene, Antithrombin alfa. The full list is on the Bazedoxifene-conjugated estrogens page.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
